A Pilot Study of the Adverse Events Caused by the Combined Use of Bevacizumab and Vascular Endothelial Growth Factor Receptor-Targeted Vaccination for Patients with a Malignant Glioma
- Resource Type
- Journal
- Source
VACCINES ; SEP 2020, 8 3, p498 9p.- Subject
- Language
- English
- ISSN
- 2076393X